BCL2 and posterior cortical atrophy: ,19,20 However, clinical translation of these therapeutic strategies for solid malignancies, including lethal PCa, has remained challenging due to the relative functional redundancy between BCL2 family proteins and “on-target” toxicities, supporting the urgent need for innovative approaches.23